Non-peptide
Empagliflozin
Also known as
Jardiance · SGLT2 inhibitor empagliflozin · empa · Jardiance 10 mg · Jardiance 25 mg
Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.
What it is
| Identity | Jardiance, an oral prescription SGLT2 blocker that lets more glucose leave through urine. |
|---|---|
| Why discussed | Glucose control, heart and kidney protection, and longevity interest; the medical outcome research does not establish longer life in healthy users. |
Notes
Empagliflozin (Jardiance) moves glucose into urine. People discuss this oral prescription drug for glucose control or heart, kidney and longevity benefits. Reports include better readings, no change, thirst, infections and serious illness.
The kidney normally takes glucose back. SGLT2 is a kidney transporter. Blocking it lets more glucose leave in urine. DailyMed — JARDIANCE prescribing information, revised January 2026 (Official context · Accessed 2026-09-30)
Longevity interest runs ahead of personal proof. The attraction is heart-and-kidney outcome research, not a reliable energizing sensation. Older discussion compares it with metformin and calls it a cheap rapamycin alternative; those nicknames and rankings do not establish equivalent effects or longer life.
Medical dosing is distinct from longevity experiments. Labeling starts at 10 mg daily; 25 mg is for additional glucose control. Heart/kidney disease indications do not establish healthy-user life extension. DailyMed — JARDIANCE prescribing information, revised January 2026 (Official context · Accessed 2026-09-30)
Source context — DailyMed — JARDIANCE prescribing information, revised January 2026: Manufacturer prescribing information distributed by NLM, not a community measurement or healthy-longevity indication. Dose-initiation and titration differ; retained as context, not a self-use instruction. Label mirrors and manufacturer reprints share one source-origin budget.
What people notice
| Glucose readings | Some report smaller food-related spikes and good control without a boost; one 10 mg user saw no glucose-monitor or A1c change after a year. |
|---|---|
| Weight | One account reports over 30 lb lost; others describe no comparable weight loss. |
| Daily burden | Thirst, frequent urination and yeast infections can outweigh better readings; some people report no detectable adverse effects. |
Notes
Better glucose readings without feeling a boost. Resident_Bitch reported good control without problems. ChrisTheDog described smaller food-related spikes and no thrush after six months. Others describe disruptive urination despite better glucose readings. r/diabetes_t2 — Jardiance, yah or nay? (Community discussion · Accessed 2026-09-30)
Protection that is hard to feel. Ziegelhausen reported a year at 10 mg without noticeable glucose-monitor or A1c change, despite glucose in urine. A1c reflects longer-term blood sugar. Hoping for protection is different from observing it. Rapamycin News — Non-diabetics taking SGLT2 inhibitors: what is your experience? (Community discussion · Accessed 2026-09-30)
Weight change is inconsistent. Successful-Call-6574 reported losing over 30 lb; a reply described no comparable loss. In another thread, TeaAndCrackers reported a spouse had no weight loss, while low-carbohydrate eating made glucose benefit difficult to attribute. These accounts do not make Jardiance a dependable fat-loss drug. r/diabetes_t2 — Jardiance? (Community discussion · Accessed 2026-09-30) · r/diabetes — Anyone have experience with Empaglflozin? (Community discussion · Accessed 2026-09-30)
Bathroom access can become the real burden. itsmrssmith described years of yeast problems and tiring urination, with self-directed travel interruptions and a later unchanged A1c. This cannot validate skipped-dose safety or heart-and-kidney protection; it explains a burden glucose charts miss. r/diabetes_t2 — Jardiance, yah or nay? (Community discussion · Accessed 2026-09-30)
Good results do not prevent a bad experience. Vivid_Map_437 described recurrent thrush. The original poster, daizeefli22, initially noted a racing heart had begun with new blood-pressure medication, then later attributed hospitalization to excessive fluid loss. Both parts matter; the thread cannot isolate which drug caused it. r/diabetes_t2 — Jardiance, yah or nay? (Community discussion · Accessed 2026-09-30)
An adverse experiment has important confounding. Danlalane reported breathlessness, racing heart, eye bags and nerve symptoms after intermittent use. Oral minoxidil had been started too; symptoms reportedly returned when empagliflozin was retried separately. RapAdmin reported no detectable adverse effects. This is disagreement, not a frequency estimate. Rapamycin News — Empagliflozin & Rapamycin? (Community discussion · Accessed 2026-09-30)
Source context — r/diabetes_t2 — Jardiance, yah or nay?: Different diseases, co-medications and duration; no denominator or verified records. Forum guarantees about hydration/cleanliness preventing infection, working through UTIs and blanket skipping advice are not adopted. Travel interruption and unchanged A1c remain one account.
Source context — Rapamycin News — Non-diabetics taking SGLT2 inhibitors: what is your experience?: Self-selected off-label reports, unverified products/labs; multiple drugs. Virilius's A1c and pallor/nausea do not diagnose hypoglycemia or ketoacidosis. CronosTempi's stated start year is internally unclear and not reproduced. No safe fasting, muscle-mass shield, prevalence or longevity inference. JSON API is the same origin as the rendered thread, not new corroboration.
Source context — r/diabetes_t2 — Jardiance?: Self-reported outcomes and side effects; weight baseline/diet unclear. plazman30's recurrent infections are one timeline. Caffeine confounds energy report. No advice to try, split tablets, self-treat infections or discontinue other medicines adopted.
Source context — r/diabetes — Anyone have experience with Empaglflozin?: TeaAndCrackers is a spouse's secondhand account. Combination amount is arinuloid's own report; daily totals are transparent arithmetic. Diet/exercise and other drugs confound weight/glucose; blanket no-weight-loss assertion and patent claims not adopted.
Source context — Rapamycin News — Empagliflozin & Rapamycin?: Same-author symptom/rechallenge and competing-drug timeline kept together. No records verify causation. RapAdmin's posts here and in 25327 are the same author over time, not independent corroboration. Unrelated canagliflozin milligrams, purchasing advice and unsupported biological claims excluded.
Doses people talk about
| Daily tablet reports | 10 mg or 25 mg orally once daily appear in patient and longevity accounts; these are prescription strengths, not established longevity doses. |
|---|---|
| Fractional experiments | Separate users report 12.5 mg daily before 25 mg, and adverse symptoms at 6.25 mg. Smaller amounts do not establish safety. |
| Combination-tablet account | 5 mg empagliflozin plus 500 mg metformin per administration twice daily: 10 mg and 1,000 mg daily respectively. |
Notes
10 mg or 25 mg orally, once daily. Daily tablet amounts appear in patient and longevity discussion. Agetron reported 25 mg daily; Ziegelhausen reported 10 mg. These borrow prescription tablet strengths rather than establish a longevity dose. Rapamycin News — Non-diabetics taking SGLT2 inhibitors: what is your experience? (Community discussion · Accessed 2026-09-30)
Fractional amounts are individual experiments. CronosTempi reported 12.5 mg daily before 25 mg; Virilius described adverse symptoms at 6.25 mg. These are separate accounts, not evidence that smaller amounts are safe. Empagliflozin milligrams are not metformin grams, and 100 mg is not a Jardiance tablet strength. Rapamycin News — Non-diabetics taking SGLT2 inhibitors: what is your experience? (Community discussion · Accessed 2026-09-30)
Combination-tablet numbers mean different ingredients. A Jardiance Duo user reported 5 mg empagliflozin plus 500 mg metformin per administration, twice daily: 10 mg and 1,000 mg daily respectively. That is a two-drug account, not 500 mg empagliflozin. r/diabetes — Anyone have experience with Empaglflozin? (Community discussion · Accessed 2026-09-30)
Source context — Rapamycin News — Non-diabetics taking SGLT2 inhibitors: what is your experience?: Self-selected off-label reports, unverified products/labs; multiple drugs. Virilius's A1c and pallor/nausea do not diagnose hypoglycemia or ketoacidosis. CronosTempi's stated start year is internally unclear and not reproduced. No safe fasting, muscle-mass shield, prevalence or longevity inference. JSON API is the same origin as the rendered thread, not new corroboration.
Source context — r/diabetes — Anyone have experience with Empaglflozin?: TeaAndCrackers is a spouse's secondhand account. Combination amount is arinuloid's own report; daily totals are transparent arithmetic. Diet/exercise and other drugs confound weight/glucose; blanket no-weight-loss assertion and patent claims not adopted.
Half-life, onset & duration
| Felt onset | Marked thirst and urination appeared on the first 10 mg day in one account. Another reported a fungal infection after three days. |
|---|---|
| Felt duration | No fixed daily felt window. Thirst eased within days for one user; frequent urination persisted for months in others. |
| Half-life | 12.4 hours in labeling; increased urinary glucose can persist about three days after a dose and is a different endpoint. |
| Blood peak | About 1.5 hours in labeling; this does not time a felt heart or kidney benefit. |
Notes
Thirst can appear on the first day. emd42 described marked thirst and frequent urination on the first 10 mg day after metformin intolerance. This establishes that person's early experience, not the time everyone should expect a glucose or heart benefit. r/diabetes_t2 — Jardiance and thirst (Community discussion · Accessed 2026-09-30)
Early glucose benefit can coexist with trouble. plazman30 described glucose readings in the 80s during three weeks of use, but a first fungal infection after three days and repeated infections that eventually led to stopping. r/diabetes_t2 — Jardiance? (Community discussion · Accessed 2026-09-30)
Thirst can ease quickly or persist for months. emd42 later said thirst became tolerable about two days after posting. DistinctMeringue still described hourly bathroom trips after roughly three months; fumbs said frequency eased over a few months. These are different timelines, not one expected adjustment period. r/diabetes_t2 — Jardiance and thirst (Community discussion · Accessed 2026-09-30)
There is no fixed daily felt window. cmdrmcgarrett described fatigue during hours 1–3, a rough first week and improvement by week three. Another user suspected increased energy but also drank substantial caffeine. Neither account measures drug action or provides a predictable daily countdown. r/diabetes_t2 — Jardiance? (Community discussion · Accessed 2026-09-30)
12.4 hours is a label measurement. Half-life describes declining blood levels; the concentration peak is 1.5 hours. Urinary glucose rises immediately and may stay elevated about three days after a dose. These are not felt duration. DailyMed — JARDIANCE prescribing information, revised January 2026 (Official context · Accessed 2026-09-30)
Protection that is hard to feel. Ziegelhausen reported a year at 10 mg without noticeable glucose-monitor or A1c change, despite glucose in urine. A1c reflects longer-term blood sugar. Hoping for protection is different from observing it. Rapamycin News — Non-diabetics taking SGLT2 inhibitors: what is your experience? (Community discussion · Accessed 2026-09-30)
Source context — r/diabetes_t2 — Jardiance and thirst: emd42's similar r/diabetes post is a potential duplicate and not counted separately. Thirst, food links and adjustment are self-reported; no usual timing, hydration amount or outcome promise follows.
Source context — r/diabetes_t2 — Jardiance?: Self-reported outcomes and side effects; weight baseline/diet unclear. plazman30's recurrent infections are one timeline. Caffeine confounds energy report. No advice to try, split tablets, self-treat infections or discontinue other medicines adopted.
Source context — DailyMed — JARDIANCE prescribing information, revised January 2026: Manufacturer prescribing information distributed by NLM, not a community measurement or healthy-longevity indication. Dose-initiation and titration differ; retained as context, not a self-use instruction. Label mirrors and manufacturer reprints share one source-origin budget.
Source context — Rapamycin News — Non-diabetics taking SGLT2 inhibitors: what is your experience?: Self-selected off-label reports, unverified products/labs; multiple drugs. Virilius's A1c and pallor/nausea do not diagnose hypoglycemia or ketoacidosis. CronosTempi's stated start year is internally unclear and not reproduced. No safe fasting, muscle-mass shield, prevalence or longevity inference. JSON API is the same origin as the rendered thread, not new corroboration.
Cycles people discuss
| Daily versus pulsed | Daily use for years and pulsing every few weeks both appear; no validated longevity on/off calendar emerges. |
|---|---|
| Illness interruptions | Medical sick-day or surgical interruption plans address illness and ketoacidosis risk; they are different from cutting cycles or self-directed travel breaks. |
Notes
Daily use and pulsing are competing practices. RapAdmin described pulsing every few weeks and pausing when oral semaglutide coincided with low energy; others report daily use for years. No validated longevity on/off calendar emerges. Rapamycin News — Non-diabetics taking SGLT2 inhibitors: what is your experience? (Community discussion · Accessed 2026-09-30)
Illness pauses are a different question. Older discussion distinguishes chronic use from a short cutting cycle and flags dehydrating illness. In the patient thread, M_Ad reported hospitalization after vomiting during a stomach upset. A clinician's sick-day or surgical interruption plan is not a bodybuilding cycle. r/diabetes_t2 — Jardiance, yah or nay? (Community discussion · Accessed 2026-09-30)
Ketoacidosis can occur without very high glucose. Vomiting, abdominal pain, weakness or breathing difficulty need urgent assessment. Illness, reduced intake, ketogenic diets, surgery and missed insulin increase risk. DailyMed — JARDIANCE prescribing information, revised January 2026 (Official context · Accessed 2026-09-30)
Bathroom access can become the real burden. itsmrssmith described years of yeast problems and tiring urination, with self-directed travel interruptions and a later unchanged A1c. This cannot validate skipped-dose safety or heart-and-kidney protection; it explains a burden glucose charts miss. r/diabetes_t2 — Jardiance, yah or nay? (Community discussion · Accessed 2026-09-30)
Source context — Rapamycin News — Non-diabetics taking SGLT2 inhibitors: what is your experience?: Self-selected off-label reports, unverified products/labs; multiple drugs. Virilius's A1c and pallor/nausea do not diagnose hypoglycemia or ketoacidosis. CronosTempi's stated start year is internally unclear and not reproduced. No safe fasting, muscle-mass shield, prevalence or longevity inference. JSON API is the same origin as the rendered thread, not new corroboration.
Source context — r/diabetes_t2 — Jardiance, yah or nay?: Different diseases, co-medications and duration; no denominator or verified records. Forum guarantees about hydration/cleanliness preventing infection, working through UTIs and blanket skipping advice are not adopted. Travel interruption and unchanged A1c remain one account.
Source context — DailyMed — JARDIANCE prescribing information, revised January 2026: Manufacturer prescribing information distributed by NLM, not a community measurement or healthy-longevity indication. Dose-initiation and titration differ; retained as context, not a self-use instruction. Label mirrors and manufacturer reprints share one source-origin budget.
Stacks
| Longevity discussion | A statin, rapamycin and an SGLT2 drug appear together; the accounts do not establish synergy. |
|---|---|
| Patient combinations | Metformin, GLP-1 drugs, blood-pressure medicines and gliclazide appear in combination accounts; effects and burdens can involve several drugs. |
| Other flozins | The original discussion warns against combining two flozins. |
Notes
Stacks make attribution difficult. Longevity discussion combines a statin, rapamycin and an SGLT2 drug. Patient accounts add empagliflozin to metformin and gliclazide. Changing drugs weakens attribution. Discussion also warns against combining two flozins; a stack screenshot does not establish synergy. r/diabetes — Anyone have experience with Empaglflozin? (Community discussion · Accessed 2026-09-30)
Longevity lists: Statins, rapamycin and an SGLT2 drug appear together. A list or screenshot does not establish synergy or combined longevity benefit. [community]
Medical combinations: Accounts include metformin, GLP-1 drugs and blood-pressure medicines. Benefits and adverse effects can involve several drugs. [community]
Other SGLT2 inhibitors: The original discussion warns against combining two flozins. It supplies no evidence that this combination improves outcomes. [community]
Source context — r/diabetes — Anyone have experience with Empaglflozin?: TeaAndCrackers is a spouse's secondhand account. Combination amount is arinuloid's own report; daily totals are transparent arithmetic. Diet/exercise and other drugs confound weight/glucose; blanket no-weight-loss assertion and patent claims not adopted.
Watch for
| Ketoacidosis | Can occur without very high glucose. Vomiting, abdominal pain, weakness or breathing difficulty need urgent assessment; illness, reduced intake, ketogenic diets and surgery raise concern. |
|---|---|
| Infection and fluid loss | Yeast/urinary infections and dehydration are recorded; fluid loss can cause dizziness and kidney-test changes. Fournier's gangrene is a serious tissue-destroying infection. |
| Other medicines | Diuretics, insulin, sulfonylureas and lithium add interaction concerns; one hospitalization account also involved a new blood-pressure medicine. |
| Pregnancy and breastfeeding | Labeling warns about fetal kidney risk, especially later pregnancy, and advises against breastfeeding. |
Notes
Ketoacidosis can occur without very high glucose. Vomiting, abdominal pain, weakness or breathing difficulty need urgent assessment. Illness, reduced intake, ketogenic diets, surgery and missed insulin increase risk. DailyMed — JARDIANCE prescribing information, revised January 2026 (Official context · Accessed 2026-09-30)
Infection and dehydration matter. Yeast and urinary infections differ; Fournier's gangrene destroys tissue. Fluid loss can cause dizziness and kidney-test changes. Diuretics, insulin, sulfonylureas and lithium add interaction concerns. DailyMed — JARDIANCE prescribing information, revised January 2026 (Official context · Accessed 2026-09-30)
Good results do not prevent a bad experience. Vivid_Map_437 described recurrent thrush. The original poster, daizeefli22, initially noted a racing heart had begun with new blood-pressure medication, then later attributed hospitalization to excessive fluid loss. Both parts matter; the thread cannot isolate which drug caused it. r/diabetes_t2 — Jardiance, yah or nay? (Community discussion · Accessed 2026-09-30)
Pregnancy and breastfeeding need separate review. Labeling warns about fetal kidney risk, especially later pregnancy, and advises against breastfeeding. Long-term healthy-user longevity safety remains unresolved. DailyMed — JARDIANCE prescribing information, revised January 2026 (Official context · Accessed 2026-09-30)
Source context — DailyMed — JARDIANCE prescribing information, revised January 2026: Manufacturer prescribing information distributed by NLM, not a community measurement or healthy-longevity indication. Dose-initiation and titration differ; retained as context, not a self-use instruction. Label mirrors and manufacturer reprints share one source-origin budget.
Source context — r/diabetes_t2 — Jardiance, yah or nay?: Different diseases, co-medications and duration; no denominator or verified records. Forum guarantees about hydration/cleanliness preventing infection, working through UTIs and blanket skipping advice are not adopted. Travel interruption and unchanged A1c remain one account.
Full notes
Empagliflozin (Jardiance) moves glucose into urine. People discuss this oral prescription drug for glucose control or heart, kidney and longevity benefits. Reports include better readings, no change, thirst, infections and serious illness.
What empagliflozin actually does
- The kidney normally takes glucose back. SGLT2 is a kidney transporter. Blocking it lets more glucose leave in urine. Official context
- A tablet, distinct from metformin and GLP-1 drugs. Comparisons often follow metformin stomach problems or Ozempic intolerance. Jardiance contains empagliflozin; combination tablets contain another drug too. It is not a reconstituted peptide or interchangeable research powder. Reddit r/diabetes_t2 Reddit r/diabetes_t2 Reddit r/diabetes Community
- Longevity interest runs ahead of personal proof. The attraction is heart-and-kidney outcome research, not a reliable energizing sensation. Older discussion compares it with metformin and calls it a cheap rapamycin alternative; those nicknames and rankings do not establish equivalent effects or longer life. Community
Benefits people seek and how it may feel
- Better glucose readings without feeling a boost. Resident_Bitch reported good control without problems. ChrisTheDog described smaller food-related spikes and no thrush after six months. Others describe disruptive urination despite better glucose readings. Reddit r/diabetes_t2
- Protection that is hard to feel. Ziegelhausen reported a year at 10 mg without noticeable glucose-monitor or A1c change, despite glucose in urine. A1c reflects longer-term blood sugar. Hoping for protection is different from observing it. Rapamycin Longevity News
- Weight change is inconsistent. Successful-Call-6574 reported losing over 30 lb; a reply described no comparable loss. In another thread, TeaAndCrackers reported a spouse had no weight loss, while low-carbohydrate eating made glucose benefit difficult to attribute. These accounts do not make Jardiance a dependable fat-loss drug. Reddit r/diabetes_t2 Reddit r/diabetes
Doses discussed
- 10 mg or 25 mg orally, once daily. Daily tablet amounts appear in patient and longevity discussion. Agetron reported 25 mg daily; Ziegelhausen reported 10 mg. These borrow prescription tablet strengths rather than establish a longevity dose. Rapamycin Longevity News
- Fractional amounts are individual experiments. CronosTempi reported 12.5 mg daily before 25 mg; Virilius described adverse symptoms at 6.25 mg. These are separate accounts, not evidence that smaller amounts are safe. Empagliflozin milligrams are not metformin grams, and 100 mg is not a Jardiance tablet strength. Rapamycin Longevity News Community
- Combination-tablet numbers mean different ingredients. A Jardiance Duo user reported 5 mg empagliflozin plus 500 mg metformin per administration, twice daily: 10 mg and 1,000 mg daily respectively. That is a two-drug account, not 500 mg empagliflozin. Reddit r/diabetes
Half-life: what community reports can tell us
- No independently measured community half-life. Daily use cannot measure how fast the drug leaves the body. The medical-label number is separate below; it is not a community estimate. Rapamycin Longevity News Community
Onset: what people first notice
- Thirst can appear on the first day. emd42 described marked thirst and frequent urination on the first 10 mg day after metformin intolerance. This establishes that person's early experience, not the time everyone should expect a glucose or heart benefit. Reddit r/diabetes_t2
- Early glucose benefit can coexist with trouble. plazman30 described glucose readings in the 80s during three weeks of use, but a first fungal infection after three days and repeated infections that eventually led to stopping. Reddit r/diabetes_t2
Duration: how experiences change
- Thirst can ease quickly or persist for months. emd42 later said thirst became tolerable about two days after posting. DistinctMeringue still described hourly bathroom trips after roughly three months; fumbs said frequency eased over a few months. These are different timelines, not one expected adjustment period. Reddit r/diabetes_t2
- There is no fixed daily felt window. cmdrmcgarrett described fatigue during hours 1–3, a rough first week and improvement by week three. Another user suspected increased energy but also drank substantial caffeine. Neither account measures drug action or provides a predictable daily countdown. Reddit r/diabetes_t2
- One hospitalization report includes a later readmission. F1BlackFlag described years of use, including 25 mg for over four years, followed by falling appetite, urinary difficulty, illness and hospitalization at reported glucose 190 mg/dL. Initial improvement and doctor-directed discontinuation were followed by renewed illness. The same writer later reported a second episode of ketoacidosis without very high glucose that month and another three-day hospital stay. This is one person's continuing account; causation, medication timing and full recovery are unverified. Personal report
Cycles and interruptions
- Daily use and pulsing are competing practices. RapAdmin described pulsing every few weeks and pausing when oral semaglutide coincided with low energy; others report daily use for years. No validated longevity on/off calendar emerges. Rapamycin Longevity News
- Illness pauses are a different question. Older discussion distinguishes chronic use from a short cutting cycle and flags dehydrating illness. In the patient thread, M_Ad reported hospitalization after vomiting during a stomach upset. A clinician's sick-day or surgical interruption plan is not a bodybuilding cycle. Community Reddit r/diabetes_t2
Cautions that matter
- Ketoacidosis can occur without very high glucose. Vomiting, abdominal pain, weakness or breathing difficulty need urgent assessment. Illness, reduced intake, ketogenic diets, surgery and missed insulin increase risk. Official context
- Infection and dehydration matter. Yeast and urinary infections differ; Fournier's gangrene destroys tissue. Fluid loss can cause dizziness and kidney-test changes. Diuretics, insulin, sulfonylureas and lithium add interaction concerns. Official context
- Pregnancy and breastfeeding need separate review. Labeling warns about fetal kidney risk, especially later pregnancy, and advises against breastfeeding. Long-term healthy-user longevity safety remains unresolved. Official context Community
What the community accounts add
- Bathroom access can become the real burden. itsmrssmith described years of yeast problems and tiring urination, with self-directed travel interruptions and a later unchanged A1c. This cannot validate skipped-dose safety or heart-and-kidney protection; it explains a burden glucose charts miss. Reddit r/diabetes_t2
- Good results do not prevent a bad experience. Vivid_Map_437 described recurrent thrush. The original poster, daizeefli22, initially noted a racing heart had begun with new blood-pressure medication, then later attributed hospitalization to excessive fluid loss. Both parts matter; the thread cannot isolate which drug caused it. Reddit r/diabetes_t2
- An adverse experiment has important confounding. Danlalane reported breathlessness, racing heart, eye bags and nerve symptoms after intermittent use. Oral minoxidil had been started too; symptoms reportedly returned when empagliflozin was retried separately. RapAdmin reported no detectable adverse effects. This is disagreement, not a frequency estimate. Rapamycin Longevity News
- Stacks make attribution difficult. Longevity discussion combines a statin, rapamycin and an SGLT2 drug. Patient accounts add empagliflozin to metformin and gliclazide. Changing drugs weakens attribution. Discussion also warns against combining two flozins; a stack screenshot does not establish synergy. Community Reddit r/diabetes
Separately measured medical context
- 12.4 hours is a label measurement. Half-life describes declining blood levels; the concentration peak is 1.5 hours. Urinary glucose rises immediately and may stay elevated about three days after a dose. These are not felt duration. Official context
- Medical dosing is distinct from longevity experiments. Labeling starts at 10 mg daily; 25 mg is for additional glucose control. Heart/kidney disease indications do not establish healthy-user life extension. Official context
